Cwm, LLC Clovis Oncology, Inc. Transaction History

Cwm, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$0.63 - $2.96 $735 - $3,454	-1,167 Reduced 79.01%	310 $1,000
Q1 2022 Apr 21, 2022	BUY	$1.43 - $3.14 $1,668 - $3,664	1,167 Added 376.45%	1,477 $3,000
Q4 2021 Jan 31, 2022	BUY	$2.7 - $4.76 $837 - $1,475	310 New	310 $1,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

Stay updated on Cwm, LLC with notifications on news.